The most common and difficult type of cancer worldwide is non-small cell lung cancer (NSCLC). Epidermal Growth element Receptor (EGFR) mutations within the landscape of NSCLC have emerged as a crucial element in diagnosis and treatment. In this thorough analysis, we will delve into the nuances of EGFR mutations, their occurrence in NSCLC, and their tremendous significance in directing the use...